Aimmune Therapeutics Initiates Phase 3 POSEIDON Trial for Treatment of Peanut Allergy in 1–3-Year-Old Children by Seini Moimoi | Dec 19, 2018 | Portfolio News
Akebia Therapeutics and Keryx Biopharmaceuticals Complete Merger, Creating Fully Integrated Renal Company by Seini Moimoi | Dec 13, 2018 | Portfolio News
Akebia Therapeutics Shareholders Approve Merger with Keryx by Seini Moimoi | Dec 11, 2018 | Portfolio News
KaNDy Therapeutics announces initiation of Phase 2b trial of NT-814 for the treatment of troublesome post-menopausal symptoms by Seini Moimoi | Dec 11, 2018 | Portfolio News
Axonics® Announces Third Quarter 2018 Financial Results and Operational Update by Seini Moimoi | Dec 11, 2018 | Portfolio News
